Founded in 2021, CanniOasis has created a theragnostic platform for the development of precision cannabinoid-based drugs that includes state-of-the-art prognostic clinical testing and molecular mapping to guide the personalized treatment of neurological disorders. A key differentiator and competitiv... Read more
Employees
1-10This company has no teams yet
This company has no offices yet